deoxycytidine and Basal Cell Cancer

deoxycytidine has been researched along with Basal Cell Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Dahl, E; Eschenbruch, J; Gaisa, NT; Gan, L; Kistermann, J; Knüchel, R; Noetzel, E; Rose, M; Rushrush, S	1

Other Studies

1 other study(ies) available for deoxycytidine and Basal Cell Cancer

Article	Year
The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells. Cells, 2021, 04-28, Volume: 10, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Adhesion; Cell Proliferation; Cisplatin; Deoxycytidine; DNA Methylation; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Neoplasms, Basal Cell; Prognosis; Promoter Regions, Genetic; Proteinase Inhibitory Proteins, Secretory; Retrospective Studies; Survival Rate; Tumor Cells, Cultured; Urinary Bladder Neoplasms	2021

Article

Year

The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells.

Cells, 2021, 04-28, Volume: 10, Issue:5

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Adhesion; Cell Proliferation; Cisplatin; Deoxycytidine; DNA Methylation; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Neoplasms, Basal Cell; Prognosis; Promoter Regions, Genetic; Proteinase Inhibitory Proteins, Secretory; Retrospective Studies; Survival Rate; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2021